This study revealed that Lrp5 in osteocytes is beneficial to reduce tumor growth in the bone, but loading-driven suppression of tumor growth can take place even in the absence of Lrp5 in osteocytes via the regulation of dopamine and cholesterol. The gene discussed is LRP5; the disease is neoplasm.